Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-blind (Data Analyst 1), Single-arm Design, Prospective, Multi-center Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders According to DSM-5

NCT06615167 is registered in ClinicalTrials.gov with HAII corp.ltd as lead sponsor.

NCT NCT06615167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06615167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-blind (Data Analyst 1), Single-arm Design, Prospective, Multi-center Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders According to DSM-5
Lead sponsor
HAII corp.ltd
Phase
Not applicable
Overall status
Recruiting
Start date
September 12, 2024
Completion date
April 30, 2025
Enrollment
122 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, major neurocognitive disorder